Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07092527 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Androgen Effects on the Reproductive Neuroendocrine Axis, 2025 Version

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date changed from estimate of Dec 1, 2025 to Dec 5, 2025v4
  2. Trial status: Not Yet Recruiting to Recruiting Primary completion date: Dec 31, 2027 to Nov 15, 2028 · Start date: Sep 30, 2025 to Dec 1, 2025 · Completion date: Dec 31, 2028 to Nov 30, 2028 · 1 morev3 Show 4 more changesShow less
    • Primary completion date: Dec 31, 2027 to Nov 15, 2028
    • Start date: Sep 30, 2025 to Dec 1, 2025
    • Completion date: Dec 31, 2028 to Nov 30, 2028
    • Site details revised
  3. Secondary endpoints: 1 to 5v2 See this version in full on ClinicalTrials.gov ↗
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This research study investigates whether male-level exogenous androgens inhibit the reproductive neuroendocrine axis in otherwise healthy (non-PCOS) females.
Trial Details
NCT Number NCT07092527
Lead Sponsor University of California, San Diego
Collaborators: National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions Transgenderism, Reproductive Issues
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov